1-4 of 4
Valérie Rolland-Neyret
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Mathieu Meunier, Sylvain Thepot, Stanislas Nimubona, Mélanie Véloso, Thibaud Lefebvre, Karim Zoubida, Martine Ropert-Bouchet, Frederic Garban, Shanti Ame, Abdesssamia Gandoul, Claire Reynes, Celia Salanoubat, Sébastien Maury, Kamel Laribi, Pirayeh Eftekhari, Jacques Delaunay, Geoffroy Venton, Clemence Santana, Stephane Cheze, Sophie Dimicoli-Salazar, Mathieu Molimard, Valérie Rolland-Neyret, Sandra David-Tchouda, Sophie Park
Journal: Blood
Blood (2024) 144 (Supplement 1): 1826.
https://doi.org/10.1182/blood-2024-198104
Published: 2024
Journal Articles

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

Laurence Legros, Françoise Boyer perrard, Dana Ranta, Lydia Roy, Mario Ojeda-Uribe, Stephane Giraudier, Nathalie Parquet, Jean Christophe Ianotto, Mathieu Wemeau, Isabelle Plantier, Franck E. Nicolini, Eric Lippert, Pascale Cony-Makhoul, Fiorenza Barraco, Laure Stalnikiewicz, Frederic Garban, Brigitte Dupriez, Francois Girodon, Anne Brignier, Yazid Arkam, Mathieu Meunier, Chloe James, Valérie Rolland-Neyret, Valerie Ugo, Pierre Morel, Marie C Bene, Jean-Jacques Kiladjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6847–6849.
https://doi.org/10.1182/blood-2022-156632
Published: 2022
Journal Articles

Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF)

Jean-Jacques Kiladjian, Jean-Christophe Ianotto, Juliette Soret, Nabih Maslah, Cendrine Chaffaut, Françoise Boyer perrard, Fiorenza Barraco, Viviane Dubruille, Claude Capron, Amandine Tisserand, Valérie Rolland-Neyret, Zineb Ghrieb, Sylvie Chevret, Isabelle Plo, Marie-Hélène Schlageter, Veronique Meignin, Matthieu Resche-Rigon, Bruno Cassinat
Journal: Blood
Blood (2022) 140 (Supplement 1): 577–578.
https://doi.org/10.1182/blood-2022-156389
Published: 2022
Journal Articles

Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis

Jean-Jacques Kiladjian, MD PhD, Juliette Soret-Dulphy, MD, Matthieu Resche-Rigon, MD PhD, Francoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Valérie Rolland-Neyret, Claude Capron, Sylvie Chevret, MD PhD, Stephane Giraudier, MD PhD, Bruno Cassinat, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 581.
https://doi.org/10.1182/blood-2018-99-110785
Published: 2018